GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (STU:X0M1) » Definitions » Earnings per Share (Diluted)

XOMA Royalty (STU:X0M1) Earnings per Share (Diluted) : €-2.29 (TTM As of Jun. 2024)


View and export this data going back to 1986. Start your Free Trial

What is XOMA Royalty Earnings per Share (Diluted)?

XOMA Royalty's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was €0.78. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-2.29.

XOMA Royalty's EPS (Basic) for the three months ended in Jun. 2024 was €0.82. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was €-2.25.

XOMA Royalty's EPS without NRI for the three months ended in Jun. 2024 was €-0.08. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was €-2.22.

During the past 13 years, XOMA Royalty's highest 3-Year average EPS without NRI Growth Rate was 68.20% per year. The lowest was -84.30% per year. And the median was 7.80% per year.


XOMA Royalty Earnings per Share (Diluted) Historical Data

The historical data trend for XOMA Royalty's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Earnings per Share (Diluted) Chart

XOMA Royalty Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.21 0.64 0.58 -1.87 -3.71

XOMA Royalty Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.56 -1.72 -0.79 0.78

Competitive Comparison of XOMA Royalty's Earnings per Share (Diluted)

For the Biotechnology subindustry, XOMA Royalty's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XOMA Royalty's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's PE Ratio distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's PE Ratio falls into.



XOMA Royalty Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

XOMA Royalty's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-37.442-5.018)/11.471
=-3.70

XOMA Royalty's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(14.85-1.271)/17.321
=0.78

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


XOMA Royalty  (STU:X0M1) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


XOMA Royalty Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


XOMA Royalty Business Description

Traded in Other Exchanges
Address
2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608
XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA Royalty Headlines

No Headlines